Interventions to improve adherence to medication in people with type 2 diabetes mellitus: A review of the literature on the role of pharmacists

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 5, 2006, Pages 409-419

  Lindenmeyer, A ^a   Hearnshaw, H ^a   Vermeire, E ^b   Van Royen, P ^b   Wens, J ^b   Biot, Y ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Adherence; Complex interventions; Patient education; Pharmacists; Type 2 diabetes mellitus

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

CLINICAL TRIAL; DRUG PACKAGING; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PHARMACIST; PRESCRIPTION; PROFESSIONAL PRACTICE; QUALITY OF LIFE; REMINDER SYSTEM; REVIEW; SYSTEMATIC REVIEW;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; PATIENT-CENTERED CARE; PHARMACEUTICAL SERVICES; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 33748358797     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00759.x     Document Type: Review

References (46)

1. International Diabetes Foundation. Diabetes e-atlas, 2004. http://www.eatlas.idf.org. Accessed 20/06/06.
2. Kinmonth AL, Griffin S, Wareham NJ (1999) Implications of the United Kingdom Prospective Diabetes Study for general practice care of type 2 diabetes. British Journal of General Practice, 49, 692-694.
3. UKPDS (1998) UK Prospective Diabetes Study 33: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352, 837-853.
4. UKPDS (1998) UK Prospective Diabetes Study 34: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet, 352, 854-865.
5. UKPDS. (1998) UK Prospective Diabetes Study 38: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ, 317, 703-713.
6. Vermeire E, Van Royen P, Coenen S et al. (1999) Insulin and type 2 diabetes. Australian Family Physician, 28, 990.
7. Wens J, Vermeire E, Driel MV (1999) The United Kingdom Prospective Diabetes Study Group: onderzoeksopzet. Minerva, 2, 122-124.
8. Goyder E, Irwig L (1998) Screening for diabetes: what are we really doing? BMJ, 317, 1644-1646.
9. Vermeire E, Hearnshaw H, Royen PV et al. (2001) Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics, 26, 331-342.
10. Nagasawa N, Smith M, Barnes J et al. (1990) Meta-analysis of correlates of diabetes patients' compliance with prescribed medications. The Diabetes Educator, 16, 192-200.
11. Cramer JA (2004) A systematic review of adherence with medications for diabetes. Diabetes Care, 27, 1218-1224.
12. ASHP (1999) American Society of Health System Pharmacists statement on the pharmacist's role in primary care. American Journal of Health-System Pharmacy, 56, 1665-1667.
13. Department of Health. (2003) National service framework for diabetes: delivery strategy. London: Department of Health.
14. RPSGB (2001) Practice Guidance for Community Pharmacists on the Care of People with Diabetes. London: The Royal Pharmaceutical Society of Great Britain.
15. Wermeille J, Bennie M, Brown I et al. (2004) Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team-a pilot study. Pharmacy World and Science, 26, 18-25.
16. Timmer JW, De Smet PAGM, Schuling J et al. (1999) Patient education to users of oral hypoglycemic agents: the perspective of Dutch community pharmacists. Pharmacy World and Science, 21, 200-204.
17. Nichols-English GJ, Provost M, Koompalum D et al. (2002) Strategies for pharmacists in the implementation of diabetes mellitus management programs - new roles in primary and collaborative care. Disease Management and Health Outcomes, 10, 783-803.
18. Rybacki JJ (2002) Improving cardiovascular health in postmenopausal women by addressing medication adherence issues. Journal of the American Pharmaceutical Association, 42, 63-71.
19. Bunting B (2005) An opportunity for our profession: what pharmacists should know about disease management. Journal of the Pharmacy Society of Wisconsin, 2005, 8-10.
20. Carter BL, Zillich AJ, Elliott WJ (2003) How pharmacists can assist physicians with controlling blood pressure. Journal of Clinical Hypertension, 5, 31-37.
21. Choe HM, Mitrovich S, Dubay D et al. (2005) Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. The American Journal of Managed Care, 11, 253-260.
22. Irons BK, Lenz RJ, Anderson SL et al. (2002) A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy, 22, 1294-1300.
23. Rothman R, Malone R, Bryant B et al. (2003) Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. American Journal of Medical Quality, 18, 51-58.
24. Odegard PS, Goo A, Hummel J et al. (2005) Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Annals of Pharmacotherapy, 39, 433-440.
25. Coast-Senior EA, Kroner BA, Kelley CL et al. (1998) Management of patients with type 2 diabetes by pharmacists in primary care clinics. Annals of Pharmacotherapy, 32, 636-641.
26. Davidson MB (2000) Effect of a pharmacist-managed diabetes care program in a free medical clinic. American Journal of Medical Quality, 15, 137-142.
27. Jaber LA (1996) Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy, 30, 238-243.
28. Matsuyama JR (1993) Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Annals of Pharmacotherapy, 27, 851-855.
29. Skaer TL, Sclar DA, Markowski DJ et al. (1993) Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures - a study of patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Pharmacy and Therapeutics, 18, 295-299.
30. Vermeire E, Wens J, Van Royen P et al. (2005) Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev CD003638, 18.
31. Roter D, Hall J, Merisca R et al. (1998) Effectiveness of interventions to improve patient compliance: a meta-analysis. Medical Care, 36, 1138-1161.
32. Gentili P, Maldonato A, Grieco R et al. (2001) Influence of patients' representations and beliefs about diabetes and its treatment to their adherence to therapy. Diabetes Nutrition and Metabolism, 14, 140-152.
33. Hearnshaw H, Lindenmeyer A (2005) What do we mean by adherence to treatment and advice for living with diabetes? a review of the literature on definitions and measurements. Diabetic Medicine, 23, 720-728. doi: 10.1111/j.1464-5491.2005.01783.x
34. Toljamo M, Hentinen M (2001) Adherence to self-care and social support. Journal of Clinical Nursing, 10, 618-627.
35. Lawton J, Ahmad N, Hallowell N et al. (2005) Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study. BMJ, 330, 1247.
36. Grant RW, Devita NG, Singer DE et al. (2003) Improving adherence and reducing medication discrepancies in patients with diabetes. Annals of Pharmacotherapy, 37, 962-969.
37. Gafarian CT, Heiby EM, Blair P et al. (1999) The Diabetes time Management Questionnaire. The Diabetes Educator, 25, 585-592.
38. Hernandez C (1997) The development and pilot testing of The Diabetes Activity Questionnaire (TDAQ): an instrument to measure adherence to the diabetes regimen. Applied Nursing Research, 10, 202-211.
39. Greco P, La Greca A, Auslander W et al. (1990) Assessing adherence in IDDM: A comparison of two methods. Diabetes, 40, 108A.
40. Kyngäs H, Duffy M, Kroll T (2000) Conceptual analysis of compliance. Journal of Clinical Nursing, 9, 5-12.
41. Reach G (2005) Role of habit in adherence to medical treatment. Diabetic Medicine, 22, 415-420.
42. Garrett DG, Martin LA (2003) The Asheville Project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program. Journal of the American Pharmaceutical Association (Washington, DC), 43, 185-190.
43. Cranor CW, Bunting BA, Christensen DB (2003) The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. Journal of the American Pharmaceutical Association (Washington, DC), 43, 173-184.
44. Hawe P, Shiell A, Riley T (2004) Complex interventions: how 'out of control' can a randomised controlled trial be? BMJ, 328, 1561-1563.
45. Lindsay B (2004) Randomized controlled trials of socially complex nursing interventions: creating bias and unreliability? Journal of Advanced Nursing, 45, 84-94.
46. MRC (2000) A framework for development and evaluation of RCTs for complex interventions to improve health. London: Medical Research Council.